Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Gamut Therapeutics SAS

GAMUT is a spin-out of the Institut de la Vision in Paris, focused on pioneering the unique research of scientific founder Dr. Deniz Dalkara and her collaborators. It was started in 2020 with seed funding from Advent France Biotechnology. Geoffroy de Ribains, Operating Partner at Advent France Biotechnology, is CEO of GAMUT Therapeutics. *

 

Period Start 2020-07-01 established (s-off)
  Group SparingVision SAS
Product Industry gene therapy eye disease
Person Person de Ribains, Geoffroy (AdBio Partners 202302– promoted to Managing Parnter joined AFB 2009 before Step Pharma + Biomunex)
     
Region Region Paris
  Country France
  Street 4 rue Thenard
  City 75005 Paris
    Address record changed: 2021-04-22
     
Basic data Employees n. a.
     
    * Document for »About Section«: SparingVision SAS. (4/20/21). "Press Release: SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of Gamut Therapeutics". Paris.
     
   
Record changed: 2024-06-07

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for SparingVision SAS


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top